Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
Hsingwen Chung
Global Epidemiology, Office of Chief Medical Officer, Johnson & Johnson, USA
Poster(s):
(019) Initial and subsequent biological therapies for patients with psoriasis vulgaris during 2010-2021 in Japan
Monday, August 26, 2024
8:00 AM – 6:00 PM
CEST